170 likes | 264 Views
GSG Briefing July 19, 2013. 2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact. Gottfried Hirnschall, Director HIV Department, WHO. ART Scale up : Progress Towards Global Targets. WHO Global ART report, 2013.
E N D
GSG Briefing July 19, 2013 2013 WHO Consolidated ARV GuidelinesSummary of Major Recommendations and Estimated Impact Gottfried Hirnschall, Director HIV Department, WHO
ART Scale up : Progress Towards Global Targets WHO Global ART report, 2013
Number of pregnant women living with HIV needing and receiving ARVs for PMTCT, 2005-2011 HIV+ pregnant women receiving ARVs for PMTCT HIV+ pregnant women needing ARVs for PMTCT 1,570,000 1,470,000 56% 14% (WHO, Global Report 2013)
Number of children acquiring HIV infection in low- and middle-income countries, 1996-2012 No ARV prophylaxis for PMTCT Current ARV prophylaxis coverage for PMTCT 800,000 pediatric infections averted ~290,000 new pediatric infections 2012 2015 goal: 40,000 new pediatric infections 2015 (WHO, Global Report 2013)
01 | Results: The gap between adult and child ART coverage in 20 high burden countries is widening Source: Global AIDS Response Progress Reporting (WHO/UNICEF/UNAIDS) and 2013 UNAIDS estimates.
WHO 2013 Consolidated ARV Guidelines HOW TO DO IT? • Service delivery • Diagnostics • Drug supply WHAT TO DO? • When to start or switch • Which regimen to use • How to monitor • Co-infections & • co-morbidities Clinical Operational Simplification and consolidation across:- Continuum of HIV care- Ages and populations- Clinical, operational and programmatic guidance- Existing and new recommendations Guidance for Programme Managers HOW TO DECIDE? • Prioritization • Equity and ethics • Monitoring & Evaluation
Key New Recommendations in 2013 WHO Guidelines Clinically relevant • Earlier initiation of ART (CD4 ≤ 500) • Immediate ART for children < 5 years • ART initiation for all pregnant and breastfeeding women (Option B/B+) and lifelong ART (Option B+) • Harmonization of ART across populations (e.g., adults and pregnant women) and age groups • Simplified, fewer, and less toxic 1st-line regimens (TDF/XTC/EFV) Operationally relevant • Use of Fixed Dose Combinations as a preferred approach • Improved patient monitoring to support better adherence and detect earlier treatment failure (increased use of VL) • Recommend task shifting, decentralization, and integration • Community based testing to complement broader HTC
Summary of Changes in Recommendations When to Start in Adults
Rationale: Shift from Option A to B+ or B • Major issue now is not “when to start” or “what to start” but “whether to stop”
Estimated impact on ART eligibility of implementing the new recommendations 2010 = 16.7 CD4 <350* 2013 = 25.9 on ART CD4 <500* <5y ** ** Number of people eligible for ART in low- and middle-income countries in million per WHO 2010 and 2013 ARV guidelines, based on end of 2012 epidemic situation ** only CD4>500, others included in adults * incl. co-infected with TB or HBV
Estimated impact on incidence and deaths of implementing the new recommendations WHO Global ART report, 2013
Estimated cost of implementing the new recommendations 10% increase of the 22-24 billion USD annually for full HIV response WHO Global ART report, 2013
Global Update on HIV Treatment 2013: Key Findings and Messages 9.7 million on ART, 1.6 more than in 2011 15 by 15 is within reach In high burden countries, ART coverage varies from 30% to 90% Many countries do well, but some need intensified support 630 000 children on ART, only 64 000 more than in 2011 Child – adult coverage gap is widening, other key populations lag behind ARVs saved 4.2 million lives and prevented 800 000 child infections HIV treatment scale-up is paying off Eligibility increase from 17 to 26 m Mortality/ incidence decline by 1/3 Switching from 2010 to 2013 guidelines will enhance impact on lives & epidemic
Next Steps • Global level • Launch of guidelines at IAS KL (30 June 2013) • Full guidelines • Short summaries in 6 UN languages + Portuguese • Regional level • Regional dissemination workshops • All regions planned for the next 3-6 months • UN and implementing partners support • Country level • Country adaptation • Policy and national guidelines updates • Implementation roll out
Find the New 2013 WHO Consolidated ARV Guidelines on www.who.int/hiv